Apomorphininjektionstherapie bei Morbus Parkinson
Odin, Per LU
; Bilsing, A.
; Durner, J.
and Honig, H.
(2011)
In Aktuelle Neurologie
38(Suppl. 1).
p.11-16
- Abstract
- Apomorphine as subcutaneous injections offers a valuable and effective treatment alternative for Parkinson patients with oral medication-resistant "off' phases. Its efficacy is stable during long-term therapy, with no signs of patient tolerance. Adverse events are usually mild. The best results are obtained with relatively young, active, and cognitively intact patients. Intermittent s.c. apomorphine therapy can improve the patients' possibilities to continue to work and to live a normal social life, by offering increased freedom and self-confidence through a reliable, quick rescue from the disabling medication-resistant off phases.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1966172
- author
- Odin, Per
LU
; Bilsing, A.
; Durner, J.
and Honig, H.
- organization
- alternative title
- Apomorphine Injection Therapy for Parkinson's Disease
- publishing date
- 2011
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- apomorphine, injection, subcutaneous, Parkinson, dopamine agonist
- in
- Aktuelle Neurologie
- volume
- 38
- issue
- Suppl. 1
- pages
- 11 - 16
- publisher
- Georg Thieme Verlag
- external identifiers
-
- wos:000289376300004
- scopus:79951988435
- ISSN
- 0302-4350
- DOI
- 10.1055/s-0030-1265967
- language
- German
- LU publication?
- yes
- id
- 44858212-84e7-4323-aee9-93989de99c02 (old id 1966172)
- date added to LUP
- 2016-04-01 11:14:19
- date last changed
- 2022-05-18 17:16:04
@article{44858212-84e7-4323-aee9-93989de99c02,
abstract = {{Apomorphine as subcutaneous injections offers a valuable and effective treatment alternative for Parkinson patients with oral medication-resistant "off' phases. Its efficacy is stable during long-term therapy, with no signs of patient tolerance. Adverse events are usually mild. The best results are obtained with relatively young, active, and cognitively intact patients. Intermittent s.c. apomorphine therapy can improve the patients' possibilities to continue to work and to live a normal social life, by offering increased freedom and self-confidence through a reliable, quick rescue from the disabling medication-resistant off phases.}},
author = {{Odin, Per and Bilsing, A. and Durner, J. and Honig, H.}},
issn = {{0302-4350}},
keywords = {{apomorphine; injection; subcutaneous; Parkinson; dopamine agonist}},
language = {{ger}},
number = {{Suppl. 1}},
pages = {{11--16}},
publisher = {{Georg Thieme Verlag}},
series = {{Aktuelle Neurologie}},
title = {{Apomorphininjektionstherapie bei Morbus Parkinson}},
url = {{http://dx.doi.org/10.1055/s-0030-1265967}},
doi = {{10.1055/s-0030-1265967}},
volume = {{38}},
year = {{2011}},
}